HIV infections

Syndicate content

Studies Suggest HIV Subtype More Deadly Than Others

Two studies led by researchers at the Johns Hopkins Bloomberg School of Public Health found that people infected with HIV in Thailand die from the disease significantly sooner than those with HIV living in other parts of the world.

Get the full story...

Restoring lives not just immune systems

The HIV/AIDS epidemic in Sub-Saharan Africa is decimating populations, depressing economies, deepening poverty and destabilizing traditional social orders. Various programs to prevent and treat HIV/AIDS have been developed, but few have demonstrated the capacity to make an on-going difference to a large number of affected individuals, their families and their communities.

Get the full story...

Early, routine testing for HIV is key to curbing the disease among teens

Half of all new HIV infections in the United States occur among 13 to 24 year olds, but adolescents rarely seek HIV testing. Now, new research from the Bradley Hasbro Children’s Research Center suggests that early and widespread testing – both in schools and community centers – may be the key to effectively curbing the spread of HIV within this age group.

Get the full story...

Study finds strong demand for HIV meds after high-risk sex

People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen, according to a new UCLA AIDS Institute study. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County.

Get the full story...

Clues to ensuring anti-HIV drugs are taken in Africa

HIV-infected patients in the African country of Tanzania were more likely to stop taking their medications and to fail treatment if they had to pay for the drugs themselves.

Get the full story...

Improvement still needed in HIV testing in high-risk groups

Since 2000, the rates of HIV testing have remained relatively low and constant in the United States, with about one third of Americans ever having had an HIV test, and less than a quarter of the people considered at high risk for contracting the virus that causes AIDS report having been tested in the past year.

Get the full story...

Good outcomes possible for HIV-infected children in Africa

Care provided by nurses and other clinicians in primary health care settings in sub-Saharan Africa can result in good outcomes for children with HIV infection. But the death rate is high during the first 90 days of therapy, pointing to a need for early intervention, according to a study in the October 24/31 issue of JAMA, a theme issue on poverty and human development.

Get the full story...

High-risk sexual practices common in 40-65 year-olds

As many as four out of ten HIV positive African-American men could be putting their partners at risk by not using condoms, according to research in the latest UK-based Journal of Advanced Nursing.

Get the full story...

Many in Africa don't continue HIV treatment

More than one-third of patients receiving HIV medication in Africa die or discontinue their treatment within two years, according to a study published in PLoS Medicine.

Get the full story...

Limiting implementation of CDC's recommendations for routine HIV testing

A new study concludes that routine testing for HIV recommended by the Centers for Disease Control (CDC) may violate many state laws. The study, published on October 10 in the online, open-access journal PLoS ONE), found that more than thirty states require specific consent before HIV testing may occur. Nearly half of them require that consent to be in writing.

Get the full story...

Nearly 1,000 new HIV diagnoses each year

The convenor of a major sexual health conference under way in Queensland says Australia's rate of HIV infection is slowly getting worse.

Get the full story...

AIDS vaccine experiment fails

An experiment aimed at getting vaccine against the AIDS virus has failed, with volunteers becoming infected with HIV anyway. Merck & Co. said Friday it is ending enrollment and vaccination of volunteers participating in the international study, which is partly funded by the U.S. National Institutes of Health.

Get the full story...